Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Are going to be absolutely crucial to this company’s future success imho.
Cashburn has risen to around £300k pm (or slightly more) probably due to increased sales amd marketing and headcount. They’ve got enough cash to last another good 12 months possibly 15 tops.
The reason the next three months are crucial is if they don’t finally land the QVH contract this time they surely never will. A decision is pending there after retendering. They have to get it don’t they? Secondly around April time is the sweet spot for new NHS budgets being allocated and this is when TO himself has stated is when the big decisions are taken.
After having castigated TO previously I’m now beginning to wonder whether all the endless patience here will, finally, begin to pay off.
They need roughly £4.7m revenue to break even which equates to around 10 single CDC contracts I believe. Or three larger Trust ones.
The other thing that I thought interesting when revisiting this was that they have now managed to achieve some kind of engagement at a national level ie.NHS England. You would assume then that if this finally gets the nod at a national level we are talking about a National roll out rather than a handful of random contracts.
“IF” so then the current SP is an absolute steal. IF!
Jon Burrows speaking last May re the sales prospects for CIRT and PSE Tests:
“So, we have a perfect storm happening here…and I’m very very happy to be able to report this to you and I can’t wait to report to you next January where this is all going…”
I think that says it all. A very confident CEO.
If one were to play devils advocate, in regard to both CIRT and PSE tests, what are the negatives? What can stop their progress in terms of growing sales? Both tests are validated and highly regarded in the industry. What can stop their ultimate success, and therefore OBD’s success? They are playing in huge markets. Are there any potential competitors out there that could steal market share? If there are comparable ones I’m not aware of them.
As Dug has already pointed out it’s not really about the historical results to end September though they should show an increase in revenue over 2022. There will be no contribution from PSE just CIRT. It’s what has happened since September that will be of particular interest.
And what the company is projecting for the coming year.
The ‘true’ drop in SP today was actually just 0.2p given we had a UT yesterday
Next weeks results will demonstrate growth in sales and revenue. The question is how much?
All the indicators point towards a good result because there was sales growth momentum in the CIRT test in the preceding results. And with 50 clinicians already acting as proxy sales people already last summer there is cause for optimism.
And for those who suggest why they haven’t already posted a sales update - they were very clear in the previous results that the next update would be in January 2024.
Paul0410 - i would only ever consider buying for a v short term trade. I haven’t been taking much notice of it recently. Bigger fish to fry.
Mark my words Newland is planning for a raise. That’s what all the recent announcements and activity is all about.
EC - re your point 2 a fundraising is now FAR more likely than Director buys. Newland has not bought any shares for eons. He just collects his huge salary. Nothing more.
Re your point 3 this is simply not possible. You do realise public listed companies are not able to release possibly price sensitive information to the market before it has been released to the market via an RNS. Or maybe you don’t realise it or you wouldn’t have said it.
I see you have been crowing about the recent brief SP rise here. I however remember you being here when the SP was considerably higher than this. It has since fallen . again because there is nothing to back it up in terms of actual revenue or sales. Just classic Newland Hyperbole.
Using the dramatic terms like ‘Breakthrough’ lol. And, of course, the Newland favourite’we are “Delighted”
Waiting for the inevitable fundraise especially now he’s on the road doing presentations. That’s a sure fire giveaway.
5085 - yes a long term hold here could yield huge returns with a patient outlook on things.
I see this stock as the no.1 potential cash generating growth micro company on the AIM market and I have invested as such.
This is a quite extraordinary opportunity.
Best day here for a good two months - mid November the last time we saw 32p.
Next week is huge. I keep recalling Jon Burrows saying as long back as last May how he ‘couldn’t wait’ to talk about the sales progress of the CIRT Test.
Not long now Jon….;)
Adam1986 - to try and spin that RNS as ‘good news’ is living in La La land. All it has done is throw major uncertainty into the market over what comes next and, just as importantly how long it will take. GM was hoping to be near production by end this year. The chances of that are now very slim indeed.
Bottom line : markets do NOT like uncertainty and that is what we have now. Clear evidence oof this is the fall in share price.
And today’s announcement just goes to show that my view that the deal with LB Group ain’t all that great was correct despite all the hand flailing on here.
It was the only one on the table at the time and that’s why they took it.
If the deal with LB WAS that good they wouldn’t be going non-exclusive. Who knows maybe someone else will offer something better that doesn’t dilute shareholders to oblivion?
And the India ‘update’? Well it might as well just have been copied and pasted from the last one and probably was. Translation: nothing has happened.
But do keep holding on folks there’s £5m left in the account to burn through!
Tom Oakley the Great Stock Market Escapologist! So am extremely poor trading update but Tom is miraculously able to mitigate by producing another jam tomorrow (make that next year) RNS on the same day! Well I never, what a clever cookie. ;)
Really it’s laughable and before anybody leaps to his defence and says it’s nothing to do with him it’s the NHS you know, they’re so slow!
Sorry it doesn’t rub anymore. More pilots, seriously? Wasn’t the Sussex one going to be the ‘template’ for the NHS. It was the ‘flagship’ after all.
I can’t help feeling that these two ‘pilots’ are merely crumbs thrown in his direction to save his face. Otherwise today’s ‘trading’ (what trading I ask?) update in isolation would’ve been acutely embarrassing.
Oh well Tom at least you can settle back in your comfy chair and let the cash continue to roll in……to your bank account
Jonny five - quote : ‘The JV was public knowledge then too.’
The JV was public knowledge but the board here including yourself plainly did not understand the finer details. Because NO ONE mentioned the elephant in the room. No one mentioned the fact that this was not a free lunch that CMET and us investors could feast on. Even GM in interviews would simply state ‘we are fully funded to production’ which, although true was lacking the reason WHY they were go8ng to be fully funded. A rather important’omission’ on his part wouldn’t you say. ;). Clearly the elephant that no one noticed, including myself, until a few weeks ago. And that’s when I changed my mind. Sad if that hurts your feelings.
What a pity you didn’t put as much research into the company you are invested in than in scouring through my posts for some petty snipe. Pathetic. And this is exactly the reason why so many people here lose money. You have no response to my actual post because you know I’m right!
Oh and as for striking the best deal possible…. They already have! Do you think that Greg Martyr would’ve accepted anything less? No. Amongst the suitors they no doubt spoke to LB’s was the most attractive. So you have to ask yourself who had most of the leverage here? Was it the multi billion dollar valued world leading no.1 Ti02 manufacturer or a tiny company with a tiny valuation?
And if you think that having drafted an agreement, an MOU, that they can go back and renegotiate something better? Ain’t gonna happen.
It’s a deal that, for sure, secures the future for the company. Is it a multi multi bagging deal that has been hyped here? Absolutely no way. It’s literally impossible with huge staged placements of shares against a company with a very small valuation.
IMHO massive dilution which the market has already long recognised and THAT is why we haven’t seen the expected SP rises to 10, 20 or whatever pence. So many posters have not understood the real reason the price has not gone back to previous levels. It’s all because of the JV.
No doubt there WILL be a small temporary spike when the JV is announced. But I forecast it will not be sustained and the share price will fall back again. As I’ve said before I think long-term it will be a decent investment and there will be a return, but it will be nothing like what some here are hoping for.